Skip to content
Home
About
Products & Services
Quality & Compliance
News & Events
Contact
Home
About
Products & Services
Quality & Compliance
News & Events
Contact
Home
/
Formulation
/
Biological Drug Product
/
mAb Formulation
/ Dupilumab biosimilar
Biological Drug Product
,
Formulation
,
mAb Formulation
Dupilumab biosimilar
Categories:
Biological Drug Product
,
Formulation
,
mAb Formulation
Description
• Phase 1 clinical trial to begin in 2024
Related products
Formulation
Isoflurane Inhalation
Formulation
Sevoflurane Inhalation
Formulation
Recombinant Human Growth Hormone for Injection
API
Bevacizumab
0
Added to cart
Close cart
Your Cart Is Empty
0
Check out our shop to see what's available
Scroll to Top